Factors influencing colorectal cancer screening participation

Antonio Z Gimeno García, Antonio Z Gimeno García

Abstract

Colorectal cancer (CRC) is a major health problem worldwide. Although population-based CRC screening is strongly recommended in average-risk population, compliance rates are still far from the desirable rates. High levels of screening uptake are necessary for the success of any screening program. Therefore, the investigation of factors influencing participation is crucial prior to design and launches a population-based organized screening campaign. Several studies have identified screening behaviour factors related to potential participants, providers, or health care system. These influencing factors can also be classified in non-modifiable (i.e., demographic factors, education, health insurance, or income) and modifiable factors (i.e., knowledge about CRC and screening, patient and provider attitudes or structural barriers for screening). Modifiable determinants are of great interest as they are plausible targets for interventions. Interventions at different levels (patient, providers or health care system) have been tested across the studies with different results. This paper analyzes factors related to CRC screening behaviour and potential interventions designed to improve screening uptake.

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010;127(12):2893–2917.
    1. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. The Lancet. 2010;375(9726):1624–1633.
    1. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.
    1. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471.
    1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. The New England Journal of Medicine. 1993;328:1365–1371.
    1. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the italian randomized controlled trial—SCORE. Journal of the National Cancer Institute. 2011;103(17):1310–1322.
    1. Calonge N, Petitti DB, DeWitt TG, et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2008;149(9):627–637.
    1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: s joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer Journal for Clinicians. 2008;58(3):130–160.
    1. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American college of gastroenterology guidelines for colorectal cancer screening 2009 [corrected] American Journal of Gastroenterology. 2009;104(3):739–750.
    1. Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Preventive Medicine. 2004;38(5):536–550.
    1. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. International Journal of Technology Assessment in Health Care. 2000;16(3):799–810.
    1. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Annals of Internal Medicine. 2000;133(8):573–584.
    1. Moss S, Ancell-Park R, Brenner H. Evaluation and interpretation of screening outcomes. In: Segnan N, Patnick J, von Karsa L, editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. 1st edition. European Union; 2010. pp. 71–102.
    1. Colorectal cancer facts & figures 2011–2013. .
    1. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Parra-Blanco A, Jiménez A. Colorectal cancer screening in a Spanish population. Medicina Clinica. 2009;133(19):736–740.
    1. Champion V. Skinner CS the health belief model. In: Glanz K, Rimer BK, Wisnanath K, editors. Health Behavior and Health Education: Theory, Research and Practice. 4th edition. San Francisco, Calif, USA: Jossey-Bass; 2008. pp. 45–65.
    1. Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annual Review of Public Health. 2010;31:399–418.
    1. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Preventive Medicine. 2003;36(5):525–535.
    1. Von Euler-Chelpin M, Brasso K, Lynge E. Determinants of participation in colorectal cancer screening with faecal occult blood testing. Journal of Public Health. 2010;32(3):395–405.
    1. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiology Biomarkers and Prevention. 2006;15(2):389–394.
    1. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC. Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. Morbidity and Mortality Weekly Report Surveillance Summaries. 2011;60(1) supplement:42–46.
    1. Brenner H, Hoffmeister M, Brenner G, Altenhofen L, Haug U. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. European Journal of Cancer. 2009;45(11):2027–2033.
    1. Courtier R, Casamitjana M, Macià F, et al. Participation in a colorectal cancer screening programme: influence of the method of contacting the target population. European Journal of Cancer Prevention. 2002;11(3):209–213.
    1. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Preventive Medicine. 1994;23(2):142–151.
    1. Thrasher JF, Cummings KM, Michalek AM, Mahoney MC, Moysich KB, Pillittere DM. Colorectal cancer screening among individuals with and without a family history. Journal of Public Health Management and Practice. 2002;8(2):1–9.
    1. Zorzi M, Barca A, Falcini F, et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiologia e Prevenzione. 2007;31(2-3):49–60.
    1. Segnan N, Senore C, Andreoni B, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Journal of the National Cancer Institute. 2005;97(5):347–357.
    1. James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethnicity and Disease. 2006;16(1):228–233.
    1. Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Preventing Chronic Disease. 2006;3(2):p. A50.
    1. Austin KL, Power E, Solarin I, Atkin WS, Wardle J, Robb KA. Perceived barriers to flexible sigmoidoscopy screening for colorectal cancer among UK ethnic minority groups: a qualitative study. Journal of Medical Screening. 2009;16(4):174–179.
    1. Natale-Pereira A, Marks J, Vega M, Mouzon D, Hudson SV, Salas-Lopez D. Barriers and facilitators for colorectal cancer screening practices in the latino community: perspectives from community leaders. Cancer Control. 2008;15(2):157–165.
    1. Goodman MJ, Ogdie A, Kanamori MJ, Cañar J, O’Malley AS. Barriers and facilitators of colorectal cancer screening among mid-Atlantic Latinos: focus group findings. Ethnicity and Disease. 2006;16(1):255–261.
    1. Hay JL, Ford JS, Klein D, et al. Adherence to colorectal cancer screening in mammography-adherent older women. Journal of Behavioral Medicine. 2003;26(6):553–576.
    1. Sun WY, Basch CE, Wolf RL, Li XJ. Factors associated with colorectal cancer screening among Chinese-Americans. Preventive Medicine. 2004;39(2):323–329.
    1. Thompson B, Coronado G, Neuhouser M, Chen L. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer. 2005;103(12):2491–2498.
    1. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. Journal of Rural Health. 2004;20(2):118–124.
    1. Blom J, Yin L, Lidén A, et al. Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. International Journal of Cancer. 2008;122(7):1618–1623.
    1. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Jiménez-Sosa A. Public awareness of colorectal cancer and screening in a Spanish population. Public Health. 2011;125(9):609–615.
    1. Kiecolt-Glaser JK, Newton TL. Marriage and health: his and hers. Psychological Bulletin. 2001;127(4):472–503.
    1. Van Jaarsveld CHM, Miles A, Edwards R, Wardle J. Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? Journal of Medical Screening. 2006;13(4):172–176.
    1. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the women’s health initiative. Preventive Medicine. 2000;31(3):261–270.
    1. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. American Journal of Gastroenterology. 2003;98(9):2082–2091.
    1. Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ. The effect of comorbid illness on receipt of cancer screening by older people. Journal of the American Geriatrics Society. 2002;50(10):1651–1658.
    1. Carlos RC, Fendrick AM, Ellis J, Bernstein SJ. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? JACR Journal of the American College of Radiology. 2004;1(10):769–776.
    1. Carlos RC, Underwood W, Fendrick AM, Bernstein SJ. Behavioral associations between prostate and colon cancer screening. Journal of the American College of Surgeons. 2005;200(2):216–223.
    1. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Preventive Medicine. 2003;37(6):627–634.
    1. Lewis SF, Jensen NM. Screening sigmoidoscopy: factors associated with utilization. Journal of General Internal Medicine. 1996;11(9):542–544.
    1. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. American Journal of Preventive Medicine. 2002;23(1):28–35.
    1. Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians. Recommendations and practices, 2006–2007. American Journal of Preventive Medicine. 2009;37(1):8–16.
    1. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value in Health. 2007;10(5):415–430.
    1. Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Medical Journal of Australia. 2001;175(4):195–198.
    1. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90.
    1. Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA. Barriers of and facilitators to physician recommendation of colorectal cancer screening. Journal of General Internal Medicine. 2007;22(12):1681–1688.
    1. Walsh JME, Terdiman JP. Colorectal cancer screening: clinical applications. Journal of the American Medical Association. 2003;289(10):1297–1302.
    1. García M, Borràs JM, Milà N, et al. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study. Preventive Medicine. 2011;52(3-4):265–267.
    1. Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Parra-Blanco A, Jiménez-Sosa A. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study. Cancer Epidemiology. 2009;33(3-4):216–222.
    1. Wardle J, Waller J, Brunswick N, Jarvis MJ. Awareness of risk factors for cancer among British adults. Public Health. 2001;115(3):173–174.
    1. Power E, Miles A, von Wagner C, Robb K, Wardle J. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncology. 2009;5(9):1371–1388.
    1. Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008;8, article 34
    1. Manning AT, Wadron R, Barry K. Poor awareness of colorectal cancer symptoms; a preventable cause of emergency and late stage presentation. Irish Journal of Medical Science. 2006;175(4):55–57.
    1. Robb K, Stubbings S, Ramirez A, et al. Public awareness of cancer in Britain: a population-based survey of adults. British Journal of Cancer. 2009;101(2) supplement 2:S18–S23.
    1. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults’ interest in participating in bowel cancer screening. Preventive Medicine. 2000;31(4):323–334.
    1. Robb KA, Miles A, Wardle J. Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiology Biomarkers and Prevention. 2004;13(3):366–372.
    1. Robb KA, Miles A, Wardle J. Perceived risk of colorectal cancer: sources of risk judgments. Cancer Epidemiology Biomarkers and Prevention. 2007;16(4):694–702.
    1. Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. Journal of the American Geriatrics Society. 2008;56(2):307–314.
    1. Greiner KA, Born W, Nollen N, Ahluwalia JS. Knowledge and perceptions of colorectal cancer screening among urban African Americans. Journal of General Internal Medicine. 2005;20(11):977–983.
    1. Stacy R, Torrence WA, Mitchell CR. Perceptions of knowledge, beliefs, and barriers to colorectal cancer screening. Journal of Cancer Education. 2008;23(4):238–240.
    1. Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Preventive Medicine. 2010;50(1-2):3–10.
    1. Jones RM, Woolf SH, Cunningham TD, et al. The relative importance of patient-reported barriers to colorectal cancer screening. American Journal of Preventive Medicine. 2010;38(5):499–507.
    1. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Preventive Medicine. 2000;31(4):410–416.
    1. Lantz PM, Dupuis L, Reding D, Krauska M, Lappe K. Peer discussions of cancer among hispanic migrant farm workers. Public Health Reports. 1994;109(4):512–520.
    1. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083–2091.
    1. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Archives of Internal Medicine. 2009;169(4):364–371.
    1. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. Journal of the National Cancer Institute. 2004;96(10):770–780.
    1. Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Annals of Internal Medicine. 2006;145(12):895–900.
    1. Weinrich SP, Weinrich MC, Atwood J, Boyd M, Greene F. Predictors of fecal occult blood screening among older socioeconomically disadvantaged Americans: a replication study. Patient Education and Counseling. 1998;34(2):103–114.
    1. Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Annals of Internal Medicine. 2000;133(10):761–769.
    1. Zapka JG, Lemon SC, Puleo E, Estabrook B, Luckmann R, Erban S. Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination. Annals of Internal Medicine. 2004;141(9):683–692.
    1. Hart AR, Barone TL, Gay SP, et al. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. Journal of Epidemiology and Community Health. 1997;51(2):187–191.
    1. Powe BD, Ntekop E, Barron M. An intervention study to increase colorectal cancer knowledge and screening among community elders. Public Health Nursing. 2004;21(5):435–442.
    1. Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. Journal of the National Medical Association. 2008;100(3):278–284.
    1. Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. Journal of Urban Health. 2005;82(2):216–224.
    1. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Annals of Internal Medicine. 2002;136(9):641–651.
    1. Federici A, Rossi PG, Bartolozzi F, Farchi S, Borgia P, Guastcchi G. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy) Cancer Causes and Control. 2006;17(1):45–52.
    1. Breslow RA, Rimer BK, Baron RC, et al. Introducing the community guide’s reviews of evidence on interventions to increase screening for breast, cervical, and colorectal cancers. American Journal of Preventive Medicine. 2008;35(1):S14–S20.
    1. Sabatino SA, Coates RJ, Uhler RJ, Breen N, Tangka F, Shaw KM. Disparities in mammography use among US women aged 40–64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005. Medical Care. 2008;46(7):692–700.
    1. Kern DE, Harris WL, Boekeloo BO, Barker LR, Hogeland P. Use of an outpatient medical record audit to achieve educational objectives: changes in residents’ performances over six years. Journal of General Internal Medicine. 1990;5(3):218–224.
    1. McPhee SJ, Bird JA, Jenkins CNH, Fordham D. Promoting cancer screening. A randomized, controlled trial of three interventions. Archives of Internal Medicine. 1989;149(8):1866–1872.
    1. Tierney WM, Hui SL, McDonald CJ. Delayed feedback of physician performance versus immediate reminders to perform preventive care. Effects on physician compliance. Medical care. 1986;24(8):659–666.
    1. Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner J, Lusk E. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. American Journal of Public Health. 1998;88(11):1699–1701.
    1. Holden DJ, Harris R, Porterfield DS, et al. Enhancing the use and quality of colorectal cancer screening. Evidence Report Technology Assessment. 2010;(190):1–195.
    1. Roetzheim RG, Christman LK, Jacobsen PB, Schroeder J, Abdulla R, Hunter S. Long-term results from a randomized controlled trial to increase cancer screening among attendees of community health centers. Annals of Family Medicine. 2005;3(2):109–114.
    1. Dietrich AJ, Tobin JN, Cassells A, et al. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. Annals of Family Medicine. 2007;5(4):320–327.
    1. Zapka JG, Lemon SC. Interventions for patients, providers, and health care organizations. Cancer. 2004;101(5):1165–1187.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren